Sec. 562.156. COMPOUNDED STERILE PREPARATION; NOTICE TO BOARD. (a) A pharmacy may not compound and dispense a sterile preparation unless the pharmacy holds a license as required by board rule.
(b) A pharmacy that compounds a sterile preparation shall notify the board:
(1) immediately of any adverse effects reported to the pharmacy or that are known by the pharmacy to be potentially attributable to a sterile preparation compounded by the pharmacy; and
(2) not later than 24 hours after the pharmacy issues a recall for a sterile preparation compounded by the pharmacy.
Added by Acts 2013, 83rd Leg., R.S., Ch. 608 (S.B. 1100), Sec. 6, eff. September 1, 2013.
Structure Texas Statutes
Subtitle J - Pharmacy and Pharmacists
Chapter 562 - Practice by License Holder
Subchapter D. Compounded and Prepackaged Drugs
Section 562.152. Compounding for Office Use
Section 562.153. Requirements for Office Use Compounding
Section 562.154. Distribution of Compounded and Prepackaged Products to Certain Pharmacies
Section 562.155. Compounding Service and Compounded Drug Products
Section 562.156. Compounded Sterile Preparation; Notice to Board